Advisers to the Food and Drug Administration voted Friday to recommend approval of a first-of-its-kind peanut allergy treatment, which can desensitize children to potentially life-threatening allergies. If the agency follows through and approves the drug, it would be the first of what’s expected to be a wave of new food allergy treatments that prevent a reaction, rather than simply treat one after the fact.
Read more at: https://beta.washingtonpost.com/health/2019/09/13/first-peanut-allergy-treatment-be-reviewed-by-fda-panel/?noredirect=on